EUVIMEDEUVIMED entdecken
Crossref

Discovery of Imidazo[1,2- a ]pyrazine Derivatives as Potent ENPP1 Inhibitors

Shiping Zhan, Yingying Zhang, Tian Cao, Ruirui Yang, Qiang Wang, Lin Huang, Rongrong Cui, Jie Yu, Haifang Meng, Yitian Wang, Sulin Zhang iD, Mingyue Zheng iD und 1 weitere

Journal of Medicinal Chemistry · 2024

DOI: 10.1021/acs.jmedchem.4c01634 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Medicinal Chemistry, 2024. Verfasst von Shiping Zhan und 12 weiteren Autor:innen. Beteiligte Einrichtung: Zhongshan Institute for Drug Discovery, Shanghai Institute of Materia Medica, Chinese Academy of Sciences, Zhongshan 528400, China. Hauptthemen laut MEDLINE: Pyrazines, Phosphoric Diester Hydrolases, Pyrophosphatases, Antineoplastic Agents. Die Arbeit wurde bisher 14-mal zitiert (Crossref) und nennt 34 Literaturangaben. Gefördert von: Youth Innovation Promotion Association of the Chinese Academy of Sciences, National Natural Science Foundation of China, High-level Innovative Research Institute.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

ENPP1 acts as a negative regulator of the cGAS-STING pathway through the hydrolysis of 2'3'-cGAMP. Inhibitors of ENPP1 are regarded as promising agents for stimulating the immune response in cancer immunotherapy. This study describes the identification and optimization of imidazo[1,2-a]pyrazine derivative 7 as a highly potent and selective ENPP1 inhibitor. Compound 7 demonstrated substantial inhibitory activity against ENPP1 with an IC50 value of 5.70 or 9.68 nM while showing weak inhibition against ENPP2 and ENPP3. Furthermore, compound 7 was shown to enhance the mRNA expression of cGAMP-induced STING pathway downstream target genes, such as IFNB1, CXCL10, and IL6. In vivo pharmacokinetic and antitumor studies showed promising results, with 7 not only exhibiting efficient pharmacokinetic properties but also enhancing the antitumor efficacy of the anti-PD-1 antibody. Treatment with 7 (80 mg/kg) combined with anti-PD-1 antibody achieved a tumor growth inhibition rate of 77.7% and improved survival in a murine model.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

PyrazinesPhosphoric Diester HydrolasesPyrophosphatasesAntineoplastic AgentsAnimalsHumansMiceStructure-Activity RelationshipImidazolesDrug DiscoveryCell Line, TumorMalePhosphodiesterase InhibitorsFemaleRats

Substanzen

PyrazinesPhosphoric Diester HydrolasesPyrophosphatasesectonucleotide pyrophosphatase phosphodiesterase 1Antineoplastic AgentsImidazolesimidazo(1,2-a)pyrazinePhosphodiesterase Inhibitors

Autor:innen und Institutionen

  • Zhongshan Institute for Drug Discovery, Shanghai Institute of Materia Medica, Chinese Academy of Sciences, Zhongshan 528400, China.
  • School of Pharmaceutical Sciences, Guangzhou Medical University, Guangzhou 511436, China.
  • School of Life Sciences, Division of Life Sciences and Medicine, University of Science and Technology of China, Hefei 230026, China.
  • The First Affiliated Hospital of USTC (Anhui Provincial Hospital), Division of Life Sciences and Medicine, University of Science and Technology of China, Hefei 230001, China.
  • School of Pharmacy, Guizhou Medical University, Guiyang 550014, China.
  • Shanghai Institute of Materia Medica, Chinese Academy of Sciences, Shanghai 201203, China.

ORCID-Profile: Sulin Zhang, Mingyue Zheng, Xiaowei Wu

Förderung

  • Youth Innovation Promotion Association of the Chinese Academy of Sciences
  • National Natural Science Foundation of China
  • High-level Innovative Research Institute

Zitieren

APA

Zhan, S., Zhang, Y., Cao, T., Yang, R., Wang, Q., Huang, L., Cui, R., Yu, J., Meng, H., Wang, Y., Zhang, S., Zheng, M., & Wu, X. (2024). Discovery of Imidazo[1,2- a ]pyrazine Derivatives as Potent ENPP1 Inhibitors. Journal of Medicinal Chemistry. https://doi.org/10.1021/acs.jmedchem.4c01634

Vancouver

Zhan S, Zhang Y, Cao T, Yang R, Wang Q, Huang L, et al. Discovery of Imidazo[1,2- a ]pyrazine Derivatives as Potent ENPP1 Inhibitors. Journal of Medicinal Chemistry. 2024. doi:10.1021/acs.jmedchem.4c01634

BibTeX
@article{Zhan2024,
  author = {Zhan, Shiping and Zhang, Yingying and Cao, Tian and Yang, Ruirui and Wang, Qiang and Huang, Lin and Cui, Rongrong and Yu, Jie and Meng, Haifang and Wang, Yitian and Zhang, Sulin and Zheng, Mingyue and Wu, Xiaowei},
  title = {Discovery of Imidazo[1,2- a ]pyrazine Derivatives as Potent ENPP1 Inhibitors},
  journal = {Journal of Medicinal Chemistry},
  year = {2024},
  doi = {10.1021/acs.jmedchem.4c01634}
}
Kostenlos starten →